Lele S - Search Results

1

Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute.

Sharma S, Odunsi K, Driscoll D, Lele S. Sharma S, et al. Among authors: lele s. Int J Gynecol Cancer. 2005 May-Jun;15(3):475-82. doi: 10.1111/j.1525-1438.2005.15311.x. Int J Gynecol Cancer. 2005. PMID: 15882172 Free article.

2

Human ovarian cancer, lymphoma spleen, and bovine milk GlcNAc:beta1,4Gal/GalNAc transferases: two molecular species in ovarian tumor and induction of GalNAcbeta1,4Glc synthesis by alpha-lactalbumin.

Chandrasekaran EV, Chawda R, Piskorz C, Locke RD, Ta A, Sharad G, Odunsi K, Lele S, Matta KL. Chandrasekaran EV, et al. Among authors: lele s. Carbohydr Res. 2001 Aug 23;334(2):105-18. doi: 10.1016/s0008-6215(01)00150-1. Carbohydr Res. 2001. PMID: 11502266

3

Pulmonary resection in metastatic uterine and cervical malignancies.

Anderson TM, McMahon JJ, Nwogu CE, Pombo MW, Urschel JD, Driscoll DL, Lele SB. Anderson TM, et al. Among authors: lele sb. Gynecol Oncol. 2001 Dec;83(3):472-6. doi: 10.1006/gyno.2001.6427. Gynecol Oncol. 2001. PMID: 11733957

4

The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.

Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL. Odunsi KO, et al. Among authors: lele s. Eur J Gynaecol Oncol. 2001;22(5):325-30. Eur J Gynaecol Oncol. 2001. PMID: 11766731

5

Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.

Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S. Anupol N, et al. Among authors: lele s. Gynecol Oncol. 2002 Jun;85(3):487-92. doi: 10.1006/gyno.2002.6653. Gynecol Oncol. 2002. PMID: 12051879

6

Evaluation of beta1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer.

Odunsi K, Ghamande S, Chandrasekaran EV, Ta A, Moysich KB, Driscoll D, Matta K, Lele S. Odunsi K, et al. Among authors: lele s. Am J Obstet Gynecol. 2002 Sep;187(3):575-80. doi: 10.1067/mob.2002.125888. Am J Obstet Gynecol. 2002. PMID: 12237630

7

Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer.

Ghamande S, Lele S, Marchetti D, Baker T, Odunsi K. Ghamande S, et al. Among authors: lele s. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):142-7. doi: 10.1046/j.1525-1438.2003.13045.x. Int J Gynecol Cancer. 2003. PMID: 12657114 Clinical Trial.

8

A human papillomavirus type 16 vaccine.

Tammela JE, Lele S, Odunsi K. Tammela JE, et al. Among authors: lele s. N Engl J Med. 2003 Apr 3;348(14):1402-5; author reply 1402-5. N Engl J Med. 2003. PMID: 12678018 No abstract available.

9

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. Odunsi K, et al. Among authors: lele s. Cancer Res. 2003 Sep 15;63(18):6076-83. Cancer Res. 2003. PMID: 14522938

10

Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.

Ghadersohi A, Odunsi K, Lele S, Collins Y, Greco WR, Winston J, Liang P, Sood AK. Ghadersohi A, et al. Among authors: lele s. Oncol Rep. 2004 Feb;11(2):453-8. Oncol Rep. 2004. PMID: 14719083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters